FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a pharmaceutical composition exhibiting cytotoxicity towards human colon carcinoma cells, characterized by being an oily solution containing alpha-pinene, beta-pinene, beta-myrcene, 1,8-cineole, sabinene, abietic acid, ginsenosides Re, Rb1, Rg2, phloroglucinol, usnic acid and a vegetable oil as a pharmaceutically acceptable solvent with the following content of components, mg/l: alpha-pinene 430 to 530; beta pinene 400 to 500; beta myrcene 300 to 400; 1,8-cineole 380 to 480; sabinene 330 to 430; abietic acid 280 to 380; ginsenoside Re 300 to 400; ginsenoside Rb1 350 to 450; ginsenoside Rg2 300 to 400; phloroglucinol 150 to 250; usnic acid 100 to 200; the vegetable oil - the rest.
EFFECT: pharmaceutical composition exhibiting cytotoxicity towards human colon carcinoma cells.
1 cl, 2 dwg, 6 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
LOW-TOXICITY PHARMACEUTICAL COMPOSITION WITH ANTICANCER ACTIVITY AGAINST CHOLANGIOCARCINOMA | 2023 |
|
RU2825942C1 |
PHARMACEUTICAL COMPOSITION EXHIBITING CYTOTOXIC EFFECT ON HUMAN BLADDER CANCER CELLS | 2018 |
|
RU2693378C1 |
PHARMACEUTICAL COMPOSITION EXHIBITING ANTIMUTAGENIC ACTION (VERSIONS) | 2012 |
|
RU2477142C1 |
INSECT REPELLENT COMPOSITION | 2020 |
|
RU2820472C2 |
COMPOSITION FOR HEART DISEASES TREATMENT, METHOD OF SPECIFIED COMPOSITION PRODUCTION AND APPLICATION OF SPECIFIED COMPOSITION | 2003 |
|
RU2328300C2 |
COMPOSITIONS AND METHODS FOR INSECT CONTROL | 2004 |
|
RU2388225C2 |
IMPROVED TERPENE-BASED COMPOSITIONS, WAYS, METHODS OF PRODUCING AND CORRESPONDING PRODUCTS | 2014 |
|
RU2691986C2 |
QUINAZOLINE DERIVATIVES INDUCING FERROPTOSIS IN METASTATIC MELANOMA CELLS AND COLON CANCER | 2019 |
|
RU2722308C1 |
NEW CHEMICAL COMPOUND THAT STIMULATES PRODUCTION OF HUMAN INTERFERON-BETA BY ACTIVATING STING SIGNALING PATHWAY AND METHOD OF ITS PREPARATION | 2023 |
|
RU2811736C1 |
SYNERGISTIC COMPOSITION OF VEGETABLE ORIGIN (VARIANTS), METHOD FOR TREATMENT OF DISEASES WITH ITS USING | 2005 |
|
RU2319494C2 |
Authors
Dates
2021-04-28—Published
2020-06-22—Filed